NASDAQ:PAVM
PAVmed Inc Stock News
$2.25
+0.0500 (+2.27%)
At Close: May 09, 2024
PAVmed Receives Formal Notification of Nasdaq Continued Listing Compliance
02:30pm, Monday, 13'th Jan 2020
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has received formal notification from the Nasdaq
DDD, NVTA among premarket gainers
02:27pm, Monday, 13'th Jan 2020
Adaptimmune Therapeutics PLC (NASDAQ:ADAP) +56% as SPEAR T-cell platform delivers initial responses in four solid tumors.Verona Pharma PLC (NASDAQ:VRNA) +54% on positive ensifentrine data.Mereo BioP
